The present application provides quinoline-3-carboxamide compounds covalently linked to a label for use in the diagnosis of an inflammatory disease at local site. The above mentioned compounds can be used to detect or image accumulation of S100A9 in the body of a subject at sites of inflammation, using in vivo non-invasive molecular imaging techniques for the detection of said compounds. Accordingly, labeled quinoline-3-carboxamide compounds can be applied to evaluate the risk of a subject of developing an inflammatory disease and to follow the progress of the disease.
本申请提供了与标签共价连接的
喹啉-3-甲酰胺化合物,用于局部炎症疾病的诊断。利用体内非侵入性分子成像技术检测上述化合物,上述化合物可用于检测或成像受试者体内S100A9在炎症部位的蓄积。因此,标记的
喹啉-3-甲酰胺化合物可用于评估受试者罹患炎症性疾病的风险,并跟踪疾病的进展情况。